Hajime Yasuda

642 total citations
55 papers, 366 citations indexed

About

Hajime Yasuda is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Hajime Yasuda has authored 55 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 23 papers in Hematology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Hajime Yasuda's work include Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers). Hajime Yasuda is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers). Hajime Yasuda collaborates with scholars based in Japan. Hajime Yasuda's co-authors include Norio Komatsu, Naoki Watanabe, Soji Morishita, Yasushi Isobe, Yusuke Ochi, Jun Ando, Kazuo Oshimi, Yoko Edahiro, Makoto Sasaki and Tomonori Ochiai and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Medicine and Frontiers in Immunology.

In The Last Decade

Hajime Yasuda

44 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hajime Yasuda Japan 11 115 111 93 74 74 55 366
László Gopcsa Hungary 13 53 0.5× 92 0.8× 132 1.4× 79 1.1× 36 0.5× 44 339
Marguerite Vignon France 10 68 0.6× 74 0.7× 114 1.2× 90 1.2× 30 0.4× 26 324
Masaaki Kume Japan 11 94 0.8× 80 0.7× 240 2.6× 242 3.3× 72 1.0× 27 543
Yasuyoshi Morita Japan 11 123 1.1× 51 0.5× 132 1.4× 80 1.1× 15 0.2× 53 333
Iuliana Vaxman Israel 13 80 0.7× 150 1.4× 147 1.6× 312 4.2× 18 0.2× 57 489
Emma Jones United Kingdom 8 61 0.5× 44 0.4× 80 0.9× 105 1.4× 43 0.6× 12 404
Rina Kansal United States 13 74 0.6× 98 0.9× 65 0.7× 63 0.9× 13 0.2× 27 359
Ana Sureda Spain 10 176 1.5× 126 1.1× 328 3.5× 126 1.7× 40 0.5× 15 544
Yoshikazu Sudo Japan 10 85 0.7× 103 0.9× 224 2.4× 64 0.9× 18 0.2× 14 369
Matthew J. Ahearne United Kingdom 13 117 1.0× 264 2.4× 25 0.3× 85 1.1× 51 0.7× 26 499

Countries citing papers authored by Hajime Yasuda

Since Specialization
Citations

This map shows the geographic impact of Hajime Yasuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hajime Yasuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hajime Yasuda more than expected).

Fields of papers citing papers by Hajime Yasuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hajime Yasuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hajime Yasuda. The network helps show where Hajime Yasuda may publish in the future.

Co-authorship network of co-authors of Hajime Yasuda

This figure shows the co-authorship network connecting the top 25 collaborators of Hajime Yasuda. A scholar is included among the top collaborators of Hajime Yasuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hajime Yasuda. Hajime Yasuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yasuda, Hajime, Jun Ando, & Miki Ando. (2025). Persistent COVID-19 in Patients With Hematological Malignancies: A Focused Review in the Omicron Era. Clinical Lymphoma Myeloma & Leukemia. 26(3). e385–e396.
2.
3.
4.
Yasuda, Hajime, et al.. (2024). Case report: Ensitrelvir for treatment of persistent COVID-19 in lymphoma patients: a report of two cases. Frontiers in Immunology. 15. 1287300–1287300. 4 indexed citations
5.
Yasuda, Hajime, Yuji Tomizawa, Makoto Sasaki, et al.. (2022). Anti-myelin-associated-glycoprotein neuropathy successfully treated with tirabrutinib. Heliyon. 8(10). e10928–e10928. 8 indexed citations
6.
Yasuda, Hajime, Makoto Sasaki, Tomoiku Takaku, et al.. (2022). Hodgkin Lymphoma on Hemodialysis Successfully Treated with Extended Courses of Brentuximab Vedotin. SHILAP Revista de lepidopterología. 15(1). 263–266. 3 indexed citations
7.
Yasuda, Hajime, et al.. (2022). Hodgkin Lymphoma on Hemodialysis: A Review of Treatment and Recommendations. Clinical Lymphoma Myeloma & Leukemia. 22(11). 805–811. 3 indexed citations
8.
Sasaki, Makoto, Hajime Yasuda, Atsushi Arakawa, et al.. (2021). Improvement in the Symptoms and VEGF Levels after Resection of an Extrame Dullary Spinal Tumor and Additional Chemotherapy in a Patient with Multiple Myeloma Complicated with POEMS Syndrome. Internal Medicine. 60(22). 3625–3630. 2 indexed citations
9.
Yasuda, Hajime, et al.. (2020). Persistent COVID-19 Pneumonia and Failure to Develop Anti-SARS-CoV-2 Antibodies During Rituximab Maintenance Therapy for Follicular Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 20(11). 774–776. 58 indexed citations
10.
Yasuda, Hajime, et al.. (2020). Successful Long-Term Ibrutinib Treatment in a Hemodialysis Patient With Leukemic Nonnodal Mantle Cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 21(2). e176–e178. 5 indexed citations
11.
Morishita, Soji, Hajime Yasuda, Hideya Kawaji, et al.. (2020). CREB3L1 overexpression as a potential diagnostic marker of Philadelphia chromosome–negative myeloproliferative neoplasms. Cancer Science. 112(2). 884–892. 9 indexed citations
12.
Yasuda, Hajime, et al.. (2019). Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis. Case Reports in Oncology. 12(3). 834–837. 1 indexed citations
13.
Yasuda, Hajime, Jun Ando, Masaaki Noguchi, et al.. (2019). Vitamin B6 deficiency is prevalent in primary and secondary myelofibrosis patients. International Journal of Hematology. 110(5). 543–549. 12 indexed citations
14.
15.
Yasuda, Hajime, Marito Araki, Tomonori Ochiai, et al.. (2018). Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms. International Journal of Hematology. 107(6). 673–680. 24 indexed citations
16.
Ando, Jun, Tomonori Ochiai, Hajime Yasuda, et al.. (2017). Acute exacerbation of organizing pneumonia leading to sudden death in a patient with sarcoidosis-lymphoma syndrome.. PubMed. 58(8). 927–932. 1 indexed citations
17.
Watanabe, Naoki, Hajime Yasuda, Soji Morishita, et al.. (2017). Richter’s Syndrome with Hypercalcemia Induced by Tumor-Associated Production of Parathyroid Hormone-Related Peptide. Case Reports in Oncology. 10(1). 123–126. 6 indexed citations
18.
Yasuda, Hajime, Yasushi Isobe, Makoto Sasaki, et al.. (2010). Suppression of eIF4E Expression by <i>L</i>-Asparaginase. Acta Haematologica. 123(4). 215–219. 5 indexed citations
19.
Isobe, Yasushi, Hajime Yasuda, Seiichi Shimizu, et al.. (2009). Activity and safety of combination chemotherapy with methotrexate, ifosfamide, l‐asparaginase and dexamethasone (MILD) for refractory lymphoid malignancies: a pilot study. European Journal Of Haematology. 84(4). 310–315. 9 indexed citations
20.
Yasuda, Hajime, Koichi Sugimoto, Yasushi Isobe, et al.. (2008). Expression levels of apoptosis‐related proteins and Ki‐67 in nasal NK / T‐cell lymphoma. European Journal Of Haematology. 82(1). 39–45. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by László Gopcsa Breakdown of academic impact, for papers by Marguerite Vignon Breakdown of academic impact, for papers by Masaaki Kume Breakdown of academic impact, for papers by Yasuyoshi Morita Breakdown of academic impact, for papers by Iuliana Vaxman Breakdown of academic impact, for papers by Emma Jones Breakdown of academic impact, for papers by Rina Kansal Breakdown of academic impact, for papers by Ana Sureda Breakdown of academic impact, for papers by Yoshikazu Sudo Breakdown of academic impact, for papers by Matthew J. Ahearne
Rankless by CCL
2026